申请人:Takayama Masami
公开号:US20090318513A1
公开(公告)日:2009-12-24
A compound represented by the general formula (I):
wherein R
1
is a hydrogen atom, a halogen atom, or the like; R
2
, R
3
, and R
4
are each independently a hydrogen atom, a halogen atom, C1-C15 alkyl optionally substituted with one or more C1-C12 alkyloxy or the like, or the like; R
5
is a hydrogen atom or the like; R
6
and R
7
are a hydrogen atom or the like; R
8
is C1-C3 alkyl or the like; R
9
is a hydrogen atom or the like), a prodrug, a pharmaceutically acceptable salt, or solvate thereof.
一种由通式(I)表示的化合物:其中R1是氢原子、卤素原子或类似物;R2、R3和R4各自独立地是氢原子、卤素原子、C1-C15烷基(可选地用一个或多个C1-C12烷氧基或类似物取代)或类似物;R5是氢原子或类似物;R6和R7是氢原子或类似物;R8是C1-C3烷基或类似物;R9是氢原子或类似物。该化合物为一种前药、药物可接受的盐或其溶剂。